Skip to main content
Canna~Fangled Abstracts

The Cannabinoid Receptor 1 and its role in influencing peripheral metabolism.

By June 21, 2013No Comments
pm2 [Epub ahead of print]

The Cannabinoid Receptor 1 and its role in influencing peripheral metabolism.


Biomedical and Lifestyle Disease Unit, College of Health and Biomedicine, Victoria University, Victoria, Australia.


Evidence from in vitro and in vivo studies have demonstrated the deleterious pathological effects of a dysregulated endocannabinoid system. Increased stimulation of the cannabinoid receptor 1 (CB1 ) and subsequent downstream cellular signalling, are both causative in the deleterious pathological effects observed in a number of diseases. When the CB1 cell signalling cascade is blocked, this results in whole body weight-loss, leading to a reduction in obesity and associated co-morbidities. In the central nervous system however CB1 antagonism results in adverse psychological side effects. Blockade of CB1 via peripheral acting compounds that do not cross the blood brain barrier have been determined to have beneficial effects in metabolic tissues such as the liver and skeletal muscle. These results support the notion that peripheral blockade of CB1 using pharmacological antagonists is a viable target for the treatment of the current epidemic of obesity and its associated co- morbidities.
This article is protected by copyright. All rights reserved.




[PubMed – as supplied by publisher]
potp font 1